FindTrial
Sign In

The effect of pregabalin combined with intercostal nerve blockade on chronic pain in thoracoscopic pneumonectomy

The effect of pregabalin combined with intercostal nerve blockade on chronic pain in thoracoscopic pneumonectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025920
Enrollment
Unknown
Registered
2019-09-14
Start date
2019-09-30
Completion date
Unknown
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

Group 1:pregabalin+CINB
Group 2:CINB
Group 3:pregabalin
Group 4:conditional anagesia

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Signed the informed consent; ASA I-III; Aged 20-80 years; Selective thoracoscopic lobectomy or segmental pulmonary resection.

Exclusion criteria

Exclusion criteria: Anaphylaxis of narcotic drugs; Have a history of chronic pain or taking analgesics; Having neurological or mental disorders; Rib fracture or inflammation of the rib membrane; Secondary surgery; History of alcohol and drug abuse; Severe organ failure and coagulation dysfunction; Severe postoperative complications occurred and were sent to ICU for further treatment. Neurovascular edema; Patients cannot communicate and cooperate normally.

Design outcomes

Primary

MeasureTime frame
NRS;—

Countries

China

Contacts

Public ContactXie Junran

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

xiejunran@zju.edu.cn+86 13858126216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026